太陽能(000591.SZ):終止高郵6.5GW高效太陽能電池製造項目、引入投資者增資擴股及員工跟投
格隆匯4月14日丨太陽能(000591.SZ)公吿稱,此前公吿披露公司全資子公司中節能太陽能科技有限公司下屬控股子公司中節能太陽能科技(鎮江)有限公司(簡稱“鎮江公司”)擬在江蘇省高郵市投資年產6.5GW高效太陽能電池項目,以及鎮江公司擬引入投資者進行增資擴股,同步實施員工跟投方案。因光伏製造行業市場情況及地方政策發生重大變化,公司經與地方政府友好協商,將終止高郵年產6.5GW高效太陽能電池項目、終止鎮江公司該次增資擴股及員工跟投方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.